3ORTALDO J R,WINKLER-PICKETT R T,YAGITA H,et al.Comparative studies of CD3^ + and CD3 ^+ CD56^+ cells:examination of morphology,functions,T cell receptor rearrangement,and pore-forming protein expression[J].Gell Immunol,1991,136(2):486 -495.
4ENNEKING W F,DUNHAM W,GEBHARDT M C,et al.A system for the function evaluation of reconstructive procedures after surgical treatment of tumors of them muscul oskeletal system[J].Clin Orthop Relat Res,1993 (286):241-246.
2Schirrmacher V, Hass C, Bonifer R. Human tumor cell modicication by virus infection:an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using newcastle disease virus[J].Gene Thera, 1999,61( 1 ) :63.
3Suzuki Y,Suzuki T, Matsunage M,et al. Gangliosodes as paramyxovirus receptor. Stuctual requirement of sialo-oligosaccharides in receptors for henagglutinating virus of Japan(Sendal virus)and new castle disease virus[J]. J Biochem(Tokvo), 1985,97 : 1189.
4Hass C,Ertel C,Gerhards R, et al. Introduction of adhesive and costimulatory immune functions into tumor cells by infection with newcastle disease virus[J]. Int J Oncol,1998,13(6) :1105.
5Termeer CC,Schirrmacher V, Brocher EB, et al. Newcastle disease virus infection induces BT-1/BT-2-independent T-cell costimulatory activity in human melanoma cells[J].Cancer Gene Ther,2000,7(2) :316.
1Middleman EJ,Choi J,Venteicher AS,etal.Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxyterminal domain[J].Mol Cell Biol,2006,26(6):2146-2159.
2Sabah M,Cummins R,Leader M,et al.Immunohistochemical detection of hTERT protein in soft tissue sarcomas:correlation with tumor grade[J].Appl Immunohistochem Mol Morphol,2006,14(2):198-202.
3Kenjiro A,Anthony W,Steve G,et al.Telomerase activity in soft tissues and bone sarcomas[J].Clin Cancer Res,2000,6(12):4776-4781.